131 related articles for article (PubMed ID: 35288533)
1. An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis.
Chen YJ; Hong WF; Liu ML; Guo X; Yu YY; Cui YH; Liu TS; Liang L
Cell Death Dis; 2022 Mar; 13(3):237. PubMed ID: 35288533
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan-Cancer.
Liu AR; Liu YN; Shen SX; Yan LR; Lv Z; Ding HX; Wang A; Yuan Y; Xu Q
Biomed Res Int; 2022; 2022():4009354. PubMed ID: 36254139
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy.
Rochette L; Meloux A; Zeller M; Malka G; Cottin Y; Vergely C
Molecules; 2020 May; 25(10):. PubMed ID: 32455902
[TBL] [Abstract][Full Text] [Related]
4. Welcome to the Family: Identification of the NAD
Ziegler M; Monné M; Nikiforov A; Agrimi G; Heiland I; Palmieri F
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34198503
[TBL] [Abstract][Full Text] [Related]
5. Association of a novel seven-gene expression signature with the disease prognosis in colon cancer patients.
Yang H; Liu H; Lin HC; Gan D; Jin W; Cui C; Yan Y; Qian Y; Han C; Wang Z
Aging (Albany NY); 2019 Oct; 11(19):8710-8727. PubMed ID: 31612869
[TBL] [Abstract][Full Text] [Related]
6. The SLC25 Carrier Family: Important Transport Proteins in Mitochondrial Physiology and Pathology.
Kunji ERS; King MS; Ruprecht JJ; Thangaratnarajah C
Physiology (Bethesda); 2020 Sep; 35(5):302-327. PubMed ID: 32783608
[TBL] [Abstract][Full Text] [Related]
7. Physiological and pathological roles of mitochondrial SLC25 carriers.
Gutiérrez-Aguilar M; Baines CP
Biochem J; 2013 Sep; 454(3):371-86. PubMed ID: 23988125
[TBL] [Abstract][Full Text] [Related]
8. SLC25 Family Member Genetic Interactions Identify a Role for
Dufay JN; Fernández-Murray JP; McMaster CR
G3 (Bethesda); 2017 Jun; 7(6):1861-1873. PubMed ID: 28404662
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of gene expression signatures associated with colon cancer from three datasets.
Gao P; He M; Zhang C; Geng C
Gene; 2018 May; 654():95-102. PubMed ID: 29408621
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial transporter family SLC25: identification, properties and physiopathology.
Palmieri F
Mol Aspects Med; 2013; 34(2-3):465-84. PubMed ID: 23266187
[TBL] [Abstract][Full Text] [Related]
11. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration.
Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W
Front Immunol; 2022; 13():959967. PubMed ID: 36177002
[TBL] [Abstract][Full Text] [Related]
12. Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system.
Haitina T; Lindblom J; Renström T; Fredriksson R
Genomics; 2006 Dec; 88(6):779-790. PubMed ID: 16949250
[TBL] [Abstract][Full Text] [Related]
13. The mitochondrial transporter family (SLC25): physiological and pathological implications.
Palmieri F
Pflugers Arch; 2004 Feb; 447(5):689-709. PubMed ID: 14598172
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
15. The human gene SLC25A29, of solute carrier family 25, encodes a mitochondrial transporter of basic amino acids.
Porcelli V; Fiermonte G; Longo A; Palmieri F
J Biol Chem; 2014 May; 289(19):13374-84. PubMed ID: 24652292
[TBL] [Abstract][Full Text] [Related]
16. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
[TBL] [Abstract][Full Text] [Related]
17. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
18. Exploration of Reduced Mitochondrial Content-Associated Gene Signature and Immunocyte Infiltration in Colon Adenocarcinoma by an Integrated Bioinformatic Analysis.
Kang J; Li N; Wang F; Wei Y; Zeng Y; Luo Q; Sun X; Xu H; Peng J; Zhou F
Front Genet; 2022; 13():832331. PubMed ID: 35464857
[No Abstract] [Full Text] [Related]
19. Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis.
Fan J; Peng Z; Zhou C; Qiu G; Tang H; Sun Y; Wang X; Li Q; Le X; Xie K
Cancer; 2008 Jul; 113(2):266-75. PubMed ID: 18470904
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer.
Ren J; Feng J; Song W; Wang C; Ge Y; Fu T
Clin Exp Med; 2020 Nov; 20(4):535-544. PubMed ID: 32772211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
